LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects

Samankaltaisia teoksia

• Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
  Tekijä: Verkaaik, M, et al.
  Julkaistu: (2011)
• Serum Adenosine Deaminase Level is High But Not Related with Disease Activity Parameters in Patients with Rheumatoid Arthritis
  Tekijä: Demir, Gülseren, et al.
  Julkaistu: (2014)
• Methotrexate efficacy and tolerability after switching from oral to subcutaneous route of administration in juvenile idiopathic arthritis
  Tekijä: Zbigniew Żuber, et al.
  Julkaistu: (2016-03-01)
• Methotrexate efficacy and tolerability after switching from oral to subcutaneous route of administration in juvenile idiopathic arthritis
  Tekijä: Żuber, Zbigniew, et al.
  Julkaistu: (2016)
• Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting
  Tekijä: Senbel, Eric, et al.
  Julkaistu: (2021)